IL3RA and neutropenia: Importantly, liver toxicity, thrombocytopenia, and neutropenia, which are frequently observed with ADCs in the clinic and in cynomolgus monkey preclinical studies [48,49], were not apparent, which was most likely due to the fact that the IL3RA-ADC toxophore metabolite is non-cell permeable.